Two More Cancer Drug Candidates Hit the Fast Track

Two experimental cancer drugs, one for ovarian cancer and one for a form of breast cancer, received Fast Track designation from the U.S. Food and Drug Administration (FDA), which will speed up the regulatory process for these medications.